Details
Arlevert Indications
Symptomatic treatment of vertigo of various origins.
Contraindications
Allergic reactions to active substances, diphenhydramine or other antihistamines of similar structure, or to any excipients.
Severe renal impairment (creatinine clearance £ 25 mL / min).
Severe hepatic impairment.
Closure glaucoma.
Convulsions.
Suspicion of increased intracranial pressure.
Alcoholism.
Urinary retention caused by disorders of the urethra and prostate.
Dosage & Administration
Adults. 1 tablet 3 times a day. Tablets are taken after a meal, do not chew and with a small amount of liquid, such as ½ cup of water.
Elderly patients. Dose adjustment is required.
Renal dysfunction. Patients with renal impairment or mild to moderate severity Arlevert® should be used with caution.
Abnormal liver function. Studies of the drug to patients with hepatic impairment have been conducted.
In general, the duration of the drug should not exceed 4 weeks. A decision on a long-term treatment should take the doctor.